Clovis Oncology (CLVS) Misses Q1 EPS by 1c

Clovis Oncology (NASDAQ: CLVS) reported Q1 EPS of ($0.44), $0.01 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $34.2 million versus the consensus estimate of $36.97 million.

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c